Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients

NCT04365517 is registered in ClinicalTrials.gov with University of Milan as lead sponsor.

NCT NCT04365517
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04365517 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients
Lead sponsor
University of Milan
Phase
Phase 3
Overall status
Unknown status
Start date
December 29, 2021
Completion date
December 30, 2022
Enrollment
170 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ckd, covid19, diabetes mellitus, type 2